Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/17/07 → 10/28/09 |
Funding
- Progenics Pharmaceuticals Incorporated: $24,919.50
A Phase 3, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI)
- Beg, Tazeen (CoPI)
- Guo, Xiaojun (CoPI)
- Poovathoor, Shaji (CoPI)
- Rosenfeld, Kenneth (PI)
- Bhangoo, Jatinder (CoPI)
- Stellaccio, Francis (CoPI)
- Wahab, Aziz (CoPI)
Project: Research